Boehringer upgrades study startup software tool

Boehringer Ingelheim has upgraded to the latest version of InnovoCommerce's innovoPOINT. The European drugmaker entered into the relationship in 2011, at which time it was seeking a tool to digitize and improve the study startup process. Having upgraded to the latest version of the system, Boehringer has gained access to a feature enabling the integration of electronic trial master files (eTMFs). Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.